- Staat
- PA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 07.03.2023
- Impfdatum
- 01.03.2023
- Beginn
- 01.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Loss of consciousness
Symptomtext
Patient became lightheaded and briefly passed out directly after vaccine administration. She came too rather quickly, rested in the office, and felt well afterwards.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No known illnesses.
- Vorgeschichte
- No chronic health conditions.
- Andere Medikamente
- No known current medications.
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 10.11.2022
- Impfdatum
- 10.11.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Symptomtext
Syncope less than 1 minute while sitting 2-3 minutes following administration of final vaccine-HPV. Patient aroused immediately afterwards after touching shoulder and calling her name. Provided oral hydration of water and monitored for an additional 15minutes. Following monitoring, escorted out of clinic accompanied by her family.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- None reported
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 09.11.2022
- Beginn
- 09.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Hypotension
Loss of consciousness
Symptomtext
Administered 3 vaccine around 11:20am on 11/9/22. At around 11:24am patient passed out while sitting in the chair. Did not fall or hit her head. Per one of the sisters, the patient did not eat today. The patient frequesntly refuses to eat or drink. Called an ambulance due to low BP and oxygenation. Vital signs have been taking every 2-3 minutes. Stable, A&O x3. When the ambulance arrived- stable vital signs. The family chose to have the patinet evaluated at the ED.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 28.08.2022
- Impfdatum
- 25.08.2022
- Beginn
- 26.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Erythema
Hypoaesthesia
Hypoaesthesia oral
Local reaction
Muscular weakness
Paraesthesia
Peripheral swelling
Throat irritation
Symptomtext
pt reported itchy throat, tingling, numbness radiating to neck and upper lip and left upper extremity. Reported redness, swelling that radiated down left arm, dizziness, and weakness to left upper extremity. Pt reported taking ibuprofen once symptoms presented. Reported to clinic 48 hours after initial vaccine administration, with decreased local reaction symptoms. Advised pt to seek urgent or emergent medical care if symptoms increased.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- unidentified auto immune disorder
- Andere Medikamente
- plaquenil
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- 02.07.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Injected limb mobility decreased
Paraesthesia
X-ray
Symptomtext
prednisone x 5 days unable to lift arm (shoulder to hand) L L hand tingles/numb at times left deltoid
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- xrays, ortho
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- ropinirole
- Allergien
- shellfish
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 94,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 03.06.2022
- Beginn
- 03.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest discomfort
Discomfort
Dizziness
Dyspnoea
Pain
Paraesthesia
Symptomtext
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Body Aches Generalized-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 20.02.2023
- Impfdatum
- 13.02.2023
- Beginn
- 14.02.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Discomfort
Lymph node pain
Lymphadenopathy
Symptomtext
Left axilla lymph nodes swelled during the night after vaccine on Monday morning and were very painful. Pt reports using a heating pad even though was advised to only use ice for inflammatory response if occurred. Took ibuprofen for continued discomfort. Reports swollen lymph nodes did go away after Saturday morning so lasted 4 days with Wednesday being the worst and then slowly getting better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lymph node pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- depression, anxiety, asthma but no issues lately and sleep apnea
- Andere Medikamente
- Centrum women's multivitamin, sertraline, Zyrtec, Buspar, Strattera,
- Allergien
- mild allergy to rice, egg, almonds, walnuts, (just makes me itchy)
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 13.10.2022
- Impfdatum
- 03.09.2022
- Beginn
- 03.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Aphasia
Back pain
Blood test normal
Chest discomfort
Disturbance in attention
Feeling abnormal
Head discomfort
Headache
Magnetic resonance imaging normal
Memory impairment
Musculoskeletal stiffness
Neck pain
Ophthalmological examination abnormal
Pain in extremity
Papilloedema
Wrong technique in product usage process
Symptomtext
Vaccine was administered by pharmacy worker, at approximately 11:30 on 9/3/2022. Staff did not swab the patient's arm with alcohol prior to injection. Primary symptom is neurological: Brain fog (ongoing), including difficulty recalling memories, concentrating, and finding the right word Brain fog started after experiencing a sudden, brief, and painful pressure in the center of the brain approximately 6 hours after vaccine administration. Physical symptoms started gradually the day of the vaccine and gradually dissipated over the next several days (soreness/stiffness in arm, neck, back, passing chest discomfort)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- MRI (October 5th) - normal result Eye exam showed bilateral papilledema Blood work all is normal (many tests)
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- OCD, autism spectrum
- Andere Medikamente
- Quetiapine ER 400mg/day Sertraline 200mg/day Levothyroxine 75 mcg/day Multivitamin Vitamin D
- Allergien
- penicillins
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 10.10.2022
- Impfdatum
- 23.08.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Myalgia
Symptomtext
The muscle in my upper right arm has been sore since the date of injection. The shot was given by the clinic. After going on leave, 12 September 2022, I was directed to my Primary Care Giver. I contacted the clinic two times about soreness prior to leave. Vaccine Manufacturer: Sanofi Pasteur / Dosage: 0.5 ml
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- CombiPatch, Iporotropium Bromide, Pantoprazole, D3, Claritin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 14.09.2022
- Impfdatum
- 09.09.2022
- Beginn
- 09.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Hypoaesthesia
Neck pain
Pain in extremity
Pyrexia
Swelling
Symptomtext
fever and chills started at 9pm, pain and numbness in the entire arm and neck on side of vaccination. Applied ice to injection site, took Alleve, minimal relief. Continued pain and swelling x 5 days, taking Alleve every 6-8 hrs.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- high blood pressure, migraines
- Andere Medikamente
- Lisinopril, Effexor, Zyrtec, Allegra
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 19.08.2022
- Impfdatum
- 05.08.2022
- Beginn
- 06.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Injection site pain
Muscle spasms
Myalgia
Pyrexia
Symptomtext
muscle pain and spasms throughout body about 14 hrs after injection, fever and chills x 1 day, injection site soreness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- COVID 04Jul22 mild symptoms x 3 days
- Vorgeschichte
- GERD Right shoulder pain
- Andere Medikamente
- Prilosec Cortisone shot in right shoulder 4 days prior
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 9,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- 29.07.2022
- Beginn
- 30.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Pain in extremity
Peripheral swelling
Skin warm
Symptomtext
Arm swollen with pain warm to touch lasted 3-4 days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- No tests
- Aktuelle Erkrankungen
- None that we are aware of
- Vorgeschichte
- None that we are aware of
- Andere Medikamente
- None that we are aware of
- Allergien
- None That we are aware of
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 15.06.2022
- Impfdatum
- 15.06.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Nausea
Pallor
Symptomtext
I had an 11 year old male here in clinic for routine immunizations. He was given TD, MCV4 and HPV #1 at 9:20am and within 1-2 minutes while still in my office he became nauseated and his facial color went pale. I had two other nurses assist with getting him to lie down and elevate his feet; he was able to talk to us about how he was feeling. Vitals taken at 9:22am B\P 110/80 Pulse: 75. We then had his sit up after a few minutes and took his B/P 115/75 and his color started to return to normal and he was no longer nauseated. We then had his stand to retake his B/P 108/60 Pulse 68. He was alert and talking and able to walk out with his mom.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 04.12.2023
- Impfdatum
- 20.11.2023
- Beginn
- 20.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
administered to a patient past its expiration date with no reported adverse event; Initial information received on 22-Nov-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 43 years old female patient who was administered Diphtherias-2/Tetanus-5 Adsorbed Toxoids No preservative Adults [Tenivac] past its expiration date with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 20-Nov-2023, the patient received a 0.5 ml dose of suspect Diphtherias-2/Tetanus-5 Adsorbed Toxoids No preservative Adults Suspension for injection (lot U7189AA, Expiry date: 30-Sep-2023 with unknown strength) via intramuscular route in unknown administration site as immunization which was past its expiration date with no reported adverse event (expired product administered) (Latency: same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 8,0
- Geschlecht
- U
- Eingang
- 14.11.2023
- Impfdatum
- 24.10.2023
- Beginn
- 24.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
expired (9/30/23) Tenivac vaccine was administered to an 8 year old child with no adverse event; Initial information received on 01-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves expired (9/30/23) tenivac vaccine that was administered to an 8 year old child with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 24-Oct-2023, the patient received a dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult, Suspension for injection lot U7189AA, expiry- 30-Sep-2023 via unknown route in unknown administration site for prophylactic vaccination (strength, dose: unknown) with no adverse event (expired product administered) (latency same day). Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 27.10.2023
- Impfdatum
- 16.10.2023
- Beginn
- 16.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
tentivac was expired for 16 days and was accidentally given to a patient with no reported adverse event; Initial information received on 18-Oct-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an 80 years old female patient where diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] was expired for 16 days and was accidentally given to a patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 16-Oct-2023, the patient received a dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection (lot U7189AA and expiration date- 30-Sep-2023) via unknown route in unknown administration site (dose, strength: not provided) for Immunisation (expired product administered) (latency- same day). Action taken- not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 25.10.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
administered expired TENIVAC with no adverse event; Initial information received on 17-Oct-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 60 years old female patient who was administered expired Diphtheria-2/Tetanus-5 Adsorbed Toxoids no Preservative Adult [Tenivac] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown expired dose of suspect Diphtheria-2/Tetanus-5 Adsorbed Toxoids no Preservative Adult Suspension for injection of lot U7189AA and expiry: 30-Sep-2023 via unknown route in unknown administration site for Immunization, with no adverse event (expired product administered) (latency: same day). No lab data was reported. Action taken was not applicable. At time of reporting, the outcome was Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 12.10.2023
- Impfdatum
- 06.10.2023
- Beginn
- 06.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Expired dose given
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 12.10.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
administered an expired tenivac with no reported adverse event; Initial information received on 06-Oct-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves 28 years old male patient who was administered an expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an expired dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection (lot U7189AA) (with an unknown strength, dosage, expiry date) via unknown route in unknown administration site for Immunization with no reported adverse event (expired product administered) (latency- same day). Reportedly, Caller wants to know what to look for and if they need to revaccinate the patient. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.10.2023
- Impfdatum
- 04.10.2023
- Beginn
- 04.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Patient was given expired tenivac with no reported adverse event; Initial information received on 04-Oct-2023 regarding an unsolicited valid non-serious case received from a Physician. This case involves an unknown age and unknown gender patient where patient was given expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 04-Oct-2023, the patient received a dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection (lot- U7189AA and expiration date- 30-Sep-2023) via unknown route in unknown administration site (dose, strength: not provided) for Immunisation (expired product administered) (latency- 4 days). Action taken- not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 05.10.2023
- Impfdatum
- 03.10.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
Vaccine was 3 days expired. No adverse symptoms, or reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- albuterol, estradiol, Finacea, Imvexy, Ketolorac, montelukast, Trelegy, Tymlos
- Allergien
- Cephalosporins, Supartz
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 03.10.2023
- Impfdatum
- 03.10.2023
- Beginn
- 03.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Reticulocyte count abnormal
Symptomtext
Vaccination expired 9/30/2023 and administered after expiration date on 10/3/2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Reticulocyte count abnormal
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- anxiety disorder attention deficit hyperactivity disorder, predominantly inattentive type atypical squamous cells of undetermined significance body mass index 30+ - obesity chronic pain syndrome depressive disorder ferritin level below reference range history of domestic violence neuropathy obsessive-compulsive disorder obstructive sleep apnea syndrome posttraumatic stress disorder reticulocyte count outside reference range
- Andere Medikamente
- Adderall B complex with C-magnesium-Zn bupropion HCl desvenlafaxine succinate ferrous sulfate Fish Oil multivitamin
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 12.09.2023
- Impfdatum
- 12.09.2023
- Beginn
- 12.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Depressed level of consciousness
Hyperhidrosis
Symptomtext
Hep A IM, Hep B IM, IPV IM, MMR Subcutaneous, Td (adult formulation) IM and Varicella Subcutaneous given per protocol using proper technique. After receiving vaccines at 9:56 am, patient reported not feeling well and started to feel dizzy, skin color was pale and clammy. V/S vital signs were taken immediately HR 49, BP 120/66 , O2 saturation at 95 percent. Provider was notified immediately while still remaining with patient. Patient started to close his eyes and nurse kept him aroused to keep him from losing consciousness, patient was still oriented person, place and location. Patient was sweating profusely and 2 ice packs were given to patient to hold on both hands by provider. Legs were elevated, and reminded patient to breath in and out and follow command given to remain consciousness, patient was instructed to move toes and squeeze hands without any problem or loss of grip. Patient was also given a small snack, and patient was able to intake with no issue. Father and Son reported not having breakfast before coming to appointment, Provider gave patient water to sip on and was able to tolerate it. Second set of Vital signs were taken at 10:03 am BP 126/79, HR 65 O2 saturation at 100 percent. Patient regained skin color and sweating has stopped. Patient was alert and oriented x3. Patient reported, " I'm feeling better now." Patient remained seated. Vital signs were taken at 10:08am BP 132/83, HR 71 O2 saturation at 100 percent. At 10:13 am, patient was instructed to stand up while nurse on the side, patient was able to stand up without assistance and take a few steps without assistance. Patient and dad were instructed to seek emergency care if symptoms arise and worsen immediately. Both Father and patient verbalized understanding. No EMS was called and were released from our care at 10:17am. VAERS report submitted. Supervisor notified.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Depressed level of consciousness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- none
- Andere Medikamente
- none taken
- Allergien
- none reported
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 8,0
- Geschlecht
- U
- Eingang
- 28.08.2023
- Impfdatum
- 24.08.2023
- Beginn
- 24.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 6,0
- Geschlecht
- U
- Eingang
- 28.08.2023
- Impfdatum
- 24.08.2023
- Beginn
- 24.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 08.06.2023
- Impfdatum
- 12.12.2022
- Beginn
- 14.12.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Immunisation reaction
Symptomtext
Adverse effect of other vaccines and biological substances, initial encounter on 2022-12-14.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immunisation reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergic rhinitis, unspecified; Acute cystitis with hematuria; Pain NOS; Special screening examination for infections with a predominantly sexual mode of transmission; Body mass index [BMI] 31.0-31.9, adult; Unspecified fall, initial encounter; Type 2 diabetes mellitus without complications; Sprain of unspecified site of right knee, initial encounter; Need for immunization against single bacterial diseases; Body mass index [BMI] 30.0-30.9, adult
- Vorgeschichte
- -
- Andere Medikamente
- CYCLOBENZAPRINE HCL 5 MG ORAL TABS
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 08.06.2023
- Impfdatum
- 03.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 25,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Immunisation reaction
Symptomtext
Adverse effect of other vaccines and biological substances, initial encounter on 2022-10-28.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immunisation reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Back pain NOS; Contusion of right back wall of thorax, initial encounter; Need for immunization against single bacterial diseases
- Vorgeschichte
- -
- Andere Medikamente
- CYCLOSPORINE 0.05 % OP EMUL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 14.04.2023
- Impfdatum
- 05.04.2023
- Beginn
- 05.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
tennivac vaccine was administered to a patient accidently as the patient was supposed to receive the tdap with no reported adverse event; Initial information received on 10-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 11 years old female patient and it was reported diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] vaccine was administered to a patient accidently as the patient was supposed to receive the tdap with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV vaccine VLP RL1 4V (yeast) (Gardasil) and meningococcal vaccine A/C/Y/W CONJ (CRM197) (Menveo) both for Prophylactic vaccination. On 05-Apr-2023, diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] vaccine suspension for injection (batch/lot number: U7189AA; expiry date: 30-Sep-2023; strength: standard; dose:0.5 mL) was administered to the patient accidently via intramuscular route in the right deltoid for immunization as the patient was supposed to receive the tdap with no reported adverse event (wrong product administered) (latency: same day). Action taken: Not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- GARDASIL; MENVEO
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 17.02.2023
- Impfdatum
- 14.02.2023
- Beginn
- 14.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
The patient was given the wrong vaccines. HPV was not due until 05/08/2023. Td was not supposed to be administered. Staff member who administered stated that she got 2 patients confused.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- n/a
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 14.02.2023
- Impfdatum
- 09.02.2023
- Beginn
- 09.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
patient received tenivac to early with no reported adverse event; Initial information received on 10-Feb-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 64 years old male patient where he received tenivac to early with no reported adverse event while receiving vaccine diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac]. The patient's past medical treatment included Tenivac in 2017. The patient's concomitant medication(s) and family history were not provided. On 09-Feb-2023, the patient received 0.5 ml daily (QD) dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection (batch number- U7189AA and expiration date- 30-Sep-2023) via intramuscular route in the left deltoid (strength: not provided) as Immunization. On 09-Feb-2023 the patient received tenivac to early with no reported adverse event (inappropriate schedule of product administration) (latency- same day) following the administration of diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult. Action taken- Not applicable. It was not reported if the patient received a corrective treatment for the event (inappropriate schedule of product administration). At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: had last Tenivac in 2017
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 20.12.2022
- Impfdatum
- 06.12.2022
- Beginn
- 06.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product storage error
Symptomtext
administered post excursion to a patient; Initial information received on 14-Dec-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 20 years old male patient to whom diphtheria -2/tetanus -5 adsorbed toxoid NO preservative adult [Tenivac] was administered post excursion, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 06-Dec-2022, the patient received an unknown dose of suspect diphtheria -2/tetanus -5 adsorbed toxoid NO preservative adult, Suspension for injection, post excursion (poor quality product administered) (strength-standard) ( lot U7189AA and expiry date - 30-Sep-2023) via intramuscular route in the left deltoid for Immunization. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 07.12.2022
- Beginn
- 08.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
There were no adverse effects after 48 hours of follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- No Known allergies
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 08.12.2022
- Impfdatum
- 07.12.2022
- Beginn
- 07.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Symptomtext
Minor previously received 1st dose in HC on 6/2/22 and second dose of vaccine on 11/7/22. Minor received a third dose on 12/7/2022. No adverse reaction
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 07.12.2022
- Impfdatum
- 28.11.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Product preparation issue
Symptomtext
Patient was given an undiluted vaccine and a larger dose (0.3mg) than he should have received.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- None were done to our knowledge
- Aktuelle Erkrankungen
- Molluscum contagiosum
- Vorgeschichte
- None
- Andere Medikamente
- Afrin Pediatric Multivitamin
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 30.11.2022
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Td was given instead of Tdap
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- Tdap was given in left arm to correct error
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- n/a
- Allergien
- PCN
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 21.11.2022
- Impfdatum
- 18.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
As per Vaccine Registry System at time of administration given too early.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Acetaminophen Ibuprofen
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
No adverse reaction. Client receive expired vaccine. Expired 8/31/2022, administered 9/1/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 19.08.2022
- Impfdatum
- 19.08.2022
- Beginn
- 19.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient received Tdap on 08/15/22. Patient then received TD on 08/19/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.07.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Poor quality product administered
Product storage error
Symptomtext
The excursion lasted for 1 hour and 5 minutes. The minimum temperature of the refrigerator reached 27.5 degrees Fahrenheit with no adverse event; vaccines were given post excursion with no reported adverse event; Initial information received on 07-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves Adult and unknown gender patient and had excursion lasted for 1 hour and 5 minutes. The minimum temperature of the refrigerator reached 27.5 degrees fahrenheit with no adverse event and vaccines were given post excursion with no reported adverse event while receiving vaccines DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC], HIB (PRP/T) VACCINE [ACT-HIB] and DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect HIB (PRP/T) VACCINE (formulation, strength, route: unknown) lot UJ589AAA in unknown administration site as Immunization. On an unknown date, the patient received an unknown dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (formulation, strength, route: unknown) lot U7189AA in unknown administration site a s Immunization. On an unknown date, the patient received an unknown dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE(formulation, strength, route: unknown) lot UJ612ABA in unknown administration site as Immunization. The patient used the products for the first time. On 24-Jun-2022, the excursion lasted for 1 hour and 5 minutes. The minimum temperature of the refrigerator reached 27.5 degrees fahrenheit with no adverse event (product storage error) (latency: same day). On an unknown date in 2022 the vaccines were given post excursion with no reported adverse event (poor quality product administered) Caller does not have the patient information available at this time. None of the other vaccines were accessed. No further information provided by reporter. This situation was reported as a medication error due to temperature excursion exceeded the stability data documented in the local labelling and additional supporting stability data and was due to human error. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the events (The excursion lasted for 1 hour and 5 minutes. The minimum temperature of the refrigerator reached 27.5 degrees Fahrenheit with no adverse event, vaccines were given post excursion with no reported adverse event). At time of reporting, the outcome was Unknown for all. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Poor quality product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 24.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Shoulder injury related to vaccine administration
Symptomtext
Patient experienced SIRVA after receiving a dose of Tenivac which was later confirmed/diagnosed by a provider.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Shoulder injury related to vaccine administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 11.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient given Tdap as fourth dose rather than Dtap..no adverse reactions on date of vaccine or day 2 via follow up call
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Orbital Fracture from bike fall last week
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 26.04.2022
- Impfdatum
- 25.04.2022
- Beginn
- 25.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
No adverse event
Symptomtext
pt stated that she had no adverse reaction to the TD pt was given her TD sooner then she needed it to be. PT had her TD back in 2019 but in my system it said she was still due for it. then when i gave the pt the TD and went to put it into system it said she was given the TD vaccination back in 2019. PT was called and notified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- chronic sinus allergies and on march 8th had numbness to right hand.
- Vorgeschichte
- dry eye, chronic back pain, IBS, Asthma, Herpeti Ginivostomatitis, anxiety, chronic duodenitis
- Andere Medikamente
- CETIRIZINE (ZYRTEC GEQ) 10MG TABLET . 2. FLUTICASONE 0.05% NASAL SPRAY 3. HYDROCHLOROTHIAZIDE 25MG TABLET 4. IBUPROFEN 400MG TABLET 5. PROAIR HFA 90MCG (8.5GM) INHALER 6. SERT
- Allergien
- pt has no known allergies
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.04.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
The vaccines were stored at 18 F for approximately 30 days with no reported adverse event; Initial information received on 11-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 9 patients who experienced the vaccines were stored at 18 f for approximately 30 days with no reported adverse event while receiving vaccines Diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [tenivac] and diphtheria-2/tetanus/5 ac pertussis vaccine [adacel] and while treated with tuberculin test [tubersol]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started taking Tubersol (tuberculin test) Solution for injection once (strength, dose :unknown) (lot - C5823BA) for Immunization, Diphtheria-2/tetanus/5 ac pertussis vaccine Suspension for injection (strength, dose : unknown) lot U73068A via unknown route in unknown administration site for immunization, Diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult ( (strength, dose :unknown) lot U7189AA via unknown route in unknown administration site for immunization. On an unknown date the patient 's developed a non-serious the vaccines were stored at 18 f for approximately 30 days with no reported adverse event (product storage error) (unknown latency) following the first dose intake of Diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [tenivac] and diphtheria-2/tetanus/5 ac pertussis vaccine and while treated with tuberculin test. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (The vaccines were stored at 18 F for approximately 30 days with no reported adverse event). At time of reporting, the outcome was Unknown for the event the vaccines were stored at 18 f for approximately 30 days with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- TUBERSOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.04.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
vaccines were stored at 18 F for approximately 30 days, with no reported adverse event; Initial information received on 11-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 9 patients of unknown demographics who were administered vaccines stored at 18 F for approximately 30 days, with no reported adverse event ,while receiving vaccines DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] and DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] and TUBERCULIN TEST [TUBERSOL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started taking TUBERSOL (TUBERCULIN TEST) Solution for injection (lot - C5823BA, 02-Jun-2023) (unknown dose via unknown route in unknown administration site) as prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE Suspension for injection (lot U73068A,11-MAR-2024) (unknown dose via unknown route in unknown administration site) as prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT Suspension for injection (lot U7189AA ,30-SEP-2023) (unknown dose via unknown route in unknown administration site) as prophylactic vaccination. On an unknown date, the patient developed a non-serious event "vaccines were stored at 18 f for approximately 30 days, with no reported adverse event "(product storage error) (unknown latency). It was reported"Caller reported a temperature excursion. The caller stated that the vaccines had been stored improperly. The vaccines were stored at 18 F for approximately 30 days. The box of ADACEL was not opened and was not administered to anyone post excursion. The caller stated that they may have administered the TENIVAC and TUBERSOL post excursion to 9 patients potentially. However, the caller did not have exact information regarding the patients. The caller stated that they will call back once they have confirmed how many and which patients received these vaccines that were no longer suitable for use." Action taken with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL), DIPHTHERIA AND TETANUS TOXOIDS (TENIVAC) and TUBERCULIN TEST (TUBERSOL) was not applicable. It was not reported if the patient received a corrective treatment for the event (vaccines were stored at 18 F for approximately 30 days, with no reported adverse event). At time of reporting, the outcome was Unknown for the event vaccines were stored at 18 f for approximately 30 days, with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- TUBERSOL
- Allergien
- -
- Vorherige Impfungen
- -
